135 related articles for article (PubMed ID: 21473170)
1. Kounis syndrome is the likely culprit in devastating stent thrombosis.
Kounis NG; Almpanis GC; Tsigkas GG; Mazarakis A
J Invasive Cardiol; 2011 Mar; 23(3):3 p preceding 88. PubMed ID: 21473170
[No Abstract] [Full Text] [Related]
2. Hypersensitivity to drug-eluting stent and stent thrombosis: Kounis or not Kounis syndrome?
Tan W; Cheng KL; Chen QX
Chin Med J (Engl); 2009 Oct; 122(19):2390-3. PubMed ID: 20079145
[No Abstract] [Full Text] [Related]
3. Drug eluting stent-induced Kounis syndrome.
Venturini E; Magni L; Kounis NG
Int J Cardiol; 2011 Jan; 146(1):e16-9. PubMed ID: 19174317
[TBL] [Abstract][Full Text] [Related]
4. Kounis syndrome and simultaneous multivessel acute coronary syndromes after successful drug-eluting stent implantation.
Kounis GN; Hahalis G; Soufras GD; Mazarakis A; Niarchos C; Kounis NG
Int J Cardiol; 2008 Jun; 127(1):146-8. PubMed ID: 17586071
[No Abstract] [Full Text] [Related]
5. Early stent thrombosis: past, present, and future.
Cook S; Windecker S
Circulation; 2009 Feb; 119(5):657-9. PubMed ID: 19204315
[No Abstract] [Full Text] [Related]
6. Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry.
Urban P; Abizaid A; Banning A; Bartorelli AL; Baux AC; Džavík V; Ellis S; Gao R; Holmes D; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Spaulding C; Worthley S;
J Am Coll Cardiol; 2011 Mar; 57(13):1445-54. PubMed ID: 21435513
[TBL] [Abstract][Full Text] [Related]
7. Kounis syndrome: a manifestation of drug-eluting stent thrombosis associated with allergic reaction to contrast material.
Kogias JS; Papadakis EX; Tsatiris CG; Hahalis G; Kounis GN; Mazarakis A; Batsolaki M; Gouvelou-Deligianni GV; Kounis NG
Int J Cardiol; 2010 Mar; 139(2):206-9. PubMed ID: 18805597
[TBL] [Abstract][Full Text] [Related]
8. Coronary stents, hypersensitivity reactions, and the Kounis syndrome.
Kounis NG; Hahalis G; Theoharides TC
J Interv Cardiol; 2007 Oct; 20(5):314-23. PubMed ID: 17880327
[TBL] [Abstract][Full Text] [Related]
9. [Surgical risk of the patients treated with DES and dual anti-platelet therapy].
Nanto S
Masui; 2010 Nov; 59 Suppl():S1-7. PubMed ID: 21688454
[No Abstract] [Full Text] [Related]
10. Perioperative management of the patient with a coronary stent.
Popescu WM
Curr Opin Anaesthesiol; 2010 Feb; 23(1):109-15. PubMed ID: 19901828
[TBL] [Abstract][Full Text] [Related]
11. Recurrent acute myocardial infarction after 32 months: very late stent thrombosis after sirolimus-eluting stent implantation.
Hou XM; Qiu XB; Fang WY
Chin Med J (Engl); 2009 Oct; 122(19):2399-400. PubMed ID: 20079148
[No Abstract] [Full Text] [Related]
12. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
Ducrocq G; Serebruany V; Tanguay JF
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
[TBL] [Abstract][Full Text] [Related]
13. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
Kumbhani DJ; Bavry AA; Bhatt DL
Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
[TBL] [Abstract][Full Text] [Related]
14. Safety of drug-eluting stents.
Windecker S; Jüni P
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):316-28. PubMed ID: 18414453
[TBL] [Abstract][Full Text] [Related]
15. Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely.
Chhatriwalla AK; Bhatt DL
Circ Cardiovasc Interv; 2008 Dec; 1(3):217-25. PubMed ID: 20031681
[No Abstract] [Full Text] [Related]
16. Drug-eluting coronary stents: hypersensitivity reactions to paclitaxel and the risk of Kounis syndrome.
Soufras GD; Kounis GN; Chiladakis JA; Kounis SA; Gouvelou-Deligianni GV; Batsolaki M; Kounis NG
Dermatology; 2009; 219(1):87-8. PubMed ID: 19246881
[No Abstract] [Full Text] [Related]
17. Bare-metal versus drug-eluting coronary stents.
Agostoni P; Vermeersch P
N Engl J Med; 2008 Jun; 358(23):2516-7; author reply 2517-8. PubMed ID: 18536096
[No Abstract] [Full Text] [Related]
18. Heightened awareness of the thrombosis potential of drug-eluting stents may save lives.
From RP; Tretsven J; O'Sullivan C
J Clin Anesth; 2008 Dec; 20(8):624-5; author reply 626. PubMed ID: 19100939
[No Abstract] [Full Text] [Related]
19. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.
Gurbel PA; DiChiara J; Tantry US
Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828
[TBL] [Abstract][Full Text] [Related]
20. Stent thrombosis and Kounis syndrome: who is guilty?
Kounis NG; Almpanis G; Mazarakis A
J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):71-2. PubMed ID: 20671574
[No Abstract] [Full Text] [Related]
[Next] [New Search]
